Inventor · disambiguated record
Mirek Dostalek
Also filed as: DOSTALEK MIREK
0 granted patents·5 pending applications·0 citations·filing 2020–2020
Technology areasC07K
Files withNOVARTIS AG5
Top patents by PatentIndex Score
5 records- 0152US2023056470A1Uses of anti-tgf-beta antibodies and checkpoint inhibitors for the treatment of proliferative diseasesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0250US2022332821A1Dosing regimen and combination therapies for multispecific antibodies targeting b-cell maturation antigenNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0349US2023057071A1Combination of anti tim-3 antibody mbg453 and anti tgf-beta antibody nis793, with or without decitabine or the anti pd-1 antibody spartalizumab, for treating myelofibrosis and myelodysplastic syndromeNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0446US2022340685A1Combination therapy with entpd2 and cd73 antibodiesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0546US2022348651A1Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapiesNOVARTIS AG·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mirek Dostalek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →